» Articles » PMID: 2317583

[Role of High-dose Chemotherapy Followed by Bone Marrow Autograft in the Treatment of Metastatic Ewing's Sarcoma in Children]

Overview
Journal Bull Cancer
Publisher Elsevier
Specialty Oncology
Date 1990 Jan 1
PMID 2317583
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty-two children were treated for metastatic Ewing sarcoma by high-dose chemotherapy followed by autologous bone marrow transplantation. Fourteen patients entered phase II studies of high-dose alkylating agents. The response rate observed was 61%. High-dose chemotherapy was used as consolidation in complete remission of 18 patients. Disease free survival appears to be better than that observed under conventional altered chemotherapy. However, with only 4/18 long term survivors, these results remain unsatisfactory, taking into account the recent encouraging results of semi-continuous conventional chemotherapy.

Citing Articles

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

Whelan J, Le Deley M, Dirksen U, Le Teuff G, Brennan B, Gaspar N J Clin Oncol. 2018; :JCO2018782516.

PMID: 30188789 PMC: 6209090. DOI: 10.1200/JCO.2018.78.2516.


High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian Centre.

Hotte S, Smith A, Bramwell V, Howson-Jan K Sarcoma. 2008; 8(2-3):63-9.

PMID: 18521397 PMC: 2395608. DOI: 10.1155/2004/329273.